Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

What a traffic jam taught me…

Non-traditional ideas could be brought to bear to increase access to healthcare services

- PMLiVE

Cipher names Gerald McDole as chair

He has experience at AstraZeneca

- PMLiVE

RBW Consulting appoints researcher

Emma-Jane Lawson joins recruitment firm

- PMLiVE

Shire’s ADHD drug fails in depression trial

Company drops Vyvanse for use in major depressive disorder

- PMLiVE

AbbVie unveils its first Asian manufacturing plant

$320m facility set for Singapore

- PMLiVE

Soriot says pipeline will speed recovery at AZ

Diabetes franchise among new products expected to return company to growth

- PMLiVE

Digital strategy and maximising its impact

Digital channels continue to be a key focus for 2014, but as pharma continues to look ahead to a digital future is there more we can be doing to enhance...

aTyr appoints rare disease expert as president

Frederic Chereau has senior experience at Shire and Genzyme

- PMLiVE

Orphan drugs: A ‘responsible’ investment

There's growing sense of responsibility in the orphan drug market, but the market remains under-exploited by companies

- PMLiVE

Merck cuts MK-3475 deals with Pfizer, Amgen and Incyte

Sees combination potential for cancer prospect

- PMLiVE

GSK starts recovery from China crisis as growth returns

Sales increase after two years of declines

- PMLiVE

FDA deems GSK anaemia drug a ‘breakthrough’

US regulator will accelerate review of Promacta

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links